The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Small diameter TIPS should lead to safely expanding the use of TIPS
J Hepatol. 2020 Sep 25;S0168-8278(20)33662-X. doi: 10.1016/j.jhep.2020.09.018.Online ahead of print.
Jaime Bosch1
Author information
1Department of Biomedical Research, Bern University; Hepatology, University Clinic for Visceral Medicine and Surgery, Inselspital, Bern (CH); University of Barcelona, IDIBAPS and CIBERehd, Barcelona (Spain). Electronic address: jaime.bosch@dbmr.unibe.ch.
Abstract
TIPS is increasingly used worldwide in the treatment of complications from of portal hypertension in advanced cirrhosis. However, its use is hampered by the risk of causing hepatic encephalopathy and of worsening liver function. Reported hemodynamic targets for guiding TIPS are too narrow for being achieved in most cases, and perhaps not entirely adequate nowadays since obtained in the pre-covered stent era. We propose that small diameter TIPS - alone or combined to pharmacological therapy or ancillary interventional radiology procedures- may overcome these limitations while maintaining its beneficial effects by itself or by associating simple additional treatments or procedures.